The High Court gave a mixed decision in July, ruling that one of Moderna’s two patents relating to the mRNA technology that ...
Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...
A federal judge in Washington D.C. cited the government’s “general immunity” in dismissing a lawsuit that accused the ...
Pfizer Inc. ( PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and ...
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another ...
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
BioNTech's updated COVID-19 vaccine that protects against one of the most recently circulating variants of the virus.